EMEA-000979-PIP01-10-M02
Key facts
Invented name |
Maci
|
Active substance |
Matrix applied characterised autologous cultured chondrocytes
|
Therapeutic area |
Other
|
Decision number |
P/0012/2018
|
PIP number |
EMEA-000979-PIP01-10-M02
|
Pharmaceutical form(s) |
Implant
|
Condition(s) / indication(s) |
Treatment of cartilage disorders
|
Route(s) of administration |
Implant use
|
Contact for public enquiries |
Vericel Denmark ApS
Tel. +1 6175885661
E-mail: maguilera@vcel.com |
Decision type |
PM: decision on the application for modification of an agreed PIP
|